Report Detail

Pharma & Healthcare Global Veterinary Maxingshigan Drug Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4650284
  • |
  • 18 November, 2025
  • |
  • Global
  • |
  • 88 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Veterinary Maxingshigan Drug market size was valued at US$ 964 million in 2024 and is forecast to a readjusted size of USD 1275 million by 2031 with a CAGR of 4.7% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Veterinary Maxingshigan Drug is a granular veterinary traditional Chinese medicine (TCM) formulation derived from the classical prescription "Maxing Shigan Tang," composed of four herbal ingredients: Ephedra (Ma Huang), Bitter Apricot Seed (Xing Ren), Gypsum (Shi Gao), and Licorice (Gan Cao). It functions to clear heat, detoxify, and relieve lung congestion, making it effective against respiratory diseases such as cough, asthma, bronchitis, and pneumonia in livestock (e.g., pigs, cattle, sheep) and pets (e.g., dogs, cats) caused by wind-heat invasion or lung heat syndrome. The granules are produced using modern extraction and concentration techniques for easy administration. Its therapeutic mechanisms include pathogen inhibition, anti-inflammatory effects, expectorant action, and immune modulation, reducing reliance on antibiotics. As a natural and convenient alternative, Veterinary Maxingshigan Granules align with antibiotic-free farming and sustainable animal husbandry practices.
This report is a detailed and comprehensive analysis for global Veterinary Maxingshigan Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Veterinary Maxingshigan Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Veterinary Maxingshigan Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Veterinary Maxingshigan Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Veterinary Maxingshigan Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Veterinary Maxingshigan Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Veterinary Maxingshigan Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bolai Yaoye, Anhui Wanshi Biopharmaceutical, Tsumura, Harbin Qianhe Animal Drug Manufacturing, Wuhan Huisheng Biotechnology, Puyer International Group, Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering, China Animal Husbandry Industry, Runda Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Veterinary Maxingshigan Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Maxingshigan Granules
Maxingshigan Oral Liquid
Market segment by Application
Pig
Chicken
Dog
Others
Major players covered
Bolai Yaoye
Anhui Wanshi Biopharmaceutical
Tsumura
Harbin Qianhe Animal Drug Manufacturing
Wuhan Huisheng Biotechnology
Puyer International Group
Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering
China Animal Husbandry Industry
Runda Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Veterinary Maxingshigan Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Veterinary Maxingshigan Drug, with price, sales quantity, revenue, and global market share of Veterinary Maxingshigan Drug from 2020 to 2025.
Chapter 3, the Veterinary Maxingshigan Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Veterinary Maxingshigan Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Veterinary Maxingshigan Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Veterinary Maxingshigan Drug.
Chapter 14 and 15, to describe Veterinary Maxingshigan Drug sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Veterinary Maxingshigan Drug Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Maxingshigan Granules
    • 1.3.3 Maxingshigan Oral Liquid
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Veterinary Maxingshigan Drug Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Pig
    • 1.4.3 Chicken
    • 1.4.4 Dog
    • 1.4.5 Others
  • 1.5 Global Veterinary Maxingshigan Drug Market Size & Forecast
    • 1.5.1 Global Veterinary Maxingshigan Drug Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Veterinary Maxingshigan Drug Sales Quantity (2020-2031)
    • 1.5.3 Global Veterinary Maxingshigan Drug Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Bolai Yaoye
    • 2.1.1 Bolai Yaoye Details
    • 2.1.2 Bolai Yaoye Major Business
    • 2.1.3 Bolai Yaoye Veterinary Maxingshigan Drug Product and Services
    • 2.1.4 Bolai Yaoye Veterinary Maxingshigan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Bolai Yaoye Recent Developments/Updates
  • 2.2 Anhui Wanshi Biopharmaceutical
    • 2.2.1 Anhui Wanshi Biopharmaceutical Details
    • 2.2.2 Anhui Wanshi Biopharmaceutical Major Business
    • 2.2.3 Anhui Wanshi Biopharmaceutical Veterinary Maxingshigan Drug Product and Services
    • 2.2.4 Anhui Wanshi Biopharmaceutical Veterinary Maxingshigan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Anhui Wanshi Biopharmaceutical Recent Developments/Updates
  • 2.3 Tsumura
    • 2.3.1 Tsumura Details
    • 2.3.2 Tsumura Major Business
    • 2.3.3 Tsumura Veterinary Maxingshigan Drug Product and Services
    • 2.3.4 Tsumura Veterinary Maxingshigan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Tsumura Recent Developments/Updates
  • 2.4 Harbin Qianhe Animal Drug Manufacturing
    • 2.4.1 Harbin Qianhe Animal Drug Manufacturing Details
    • 2.4.2 Harbin Qianhe Animal Drug Manufacturing Major Business
    • 2.4.3 Harbin Qianhe Animal Drug Manufacturing Veterinary Maxingshigan Drug Product and Services
    • 2.4.4 Harbin Qianhe Animal Drug Manufacturing Veterinary Maxingshigan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Harbin Qianhe Animal Drug Manufacturing Recent Developments/Updates
  • 2.5 Wuhan Huisheng Biotechnology
    • 2.5.1 Wuhan Huisheng Biotechnology Details
    • 2.5.2 Wuhan Huisheng Biotechnology Major Business
    • 2.5.3 Wuhan Huisheng Biotechnology Veterinary Maxingshigan Drug Product and Services
    • 2.5.4 Wuhan Huisheng Biotechnology Veterinary Maxingshigan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Wuhan Huisheng Biotechnology Recent Developments/Updates
  • 2.6 Puyer International Group
    • 2.6.1 Puyer International Group Details
    • 2.6.2 Puyer International Group Major Business
    • 2.6.3 Puyer International Group Veterinary Maxingshigan Drug Product and Services
    • 2.6.4 Puyer International Group Veterinary Maxingshigan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Puyer International Group Recent Developments/Updates
  • 2.7 Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering
    • 2.7.1 Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering Details
    • 2.7.2 Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering Major Business
    • 2.7.3 Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering Veterinary Maxingshigan Drug Product and Services
    • 2.7.4 Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering Veterinary Maxingshigan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Yinghe (Jiaozuo) Traditional Chinese Medicine Bioengineering Recent Developments/Updates
  • 2.8 China Animal Husbandry Industry
    • 2.8.1 China Animal Husbandry Industry Details
    • 2.8.2 China Animal Husbandry Industry Major Business
    • 2.8.3 China Animal Husbandry Industry Veterinary Maxingshigan Drug Product and Services
    • 2.8.4 China Animal Husbandry Industry Veterinary Maxingshigan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 China Animal Husbandry Industry Recent Developments/Updates
  • 2.9 Runda Biotechnology
    • 2.9.1 Runda Biotechnology Details
    • 2.9.2 Runda Biotechnology Major Business
    • 2.9.3 Runda Biotechnology Veterinary Maxingshigan Drug Product and Services
    • 2.9.4 Runda Biotechnology Veterinary Maxingshigan Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Runda Biotechnology Recent Developments/Updates

3 Competitive Environment: Veterinary Maxingshigan Drug by Manufacturer

  • 3.1 Global Veterinary Maxingshigan Drug Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Veterinary Maxingshigan Drug Revenue by Manufacturer (2020-2025)
  • 3.3 Global Veterinary Maxingshigan Drug Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Veterinary Maxingshigan Drug by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Veterinary Maxingshigan Drug Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Veterinary Maxingshigan Drug Manufacturer Market Share in 2024
  • 3.5 Veterinary Maxingshigan Drug Market: Overall Company Footprint Analysis
    • 3.5.1 Veterinary Maxingshigan Drug Market: Region Footprint
    • 3.5.2 Veterinary Maxingshigan Drug Market: Company Product Type Footprint
    • 3.5.3 Veterinary Maxingshigan Drug Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Veterinary Maxingshigan Drug Market Size by Region
    • 4.1.1 Global Veterinary Maxingshigan Drug Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Veterinary Maxingshigan Drug Consumption Value by Region (2020-2031)
    • 4.1.3 Global Veterinary Maxingshigan Drug Average Price by Region (2020-2031)
  • 4.2 North America Veterinary Maxingshigan Drug Consumption Value (2020-2031)
  • 4.3 Europe Veterinary Maxingshigan Drug Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Veterinary Maxingshigan Drug Consumption Value (2020-2031)
  • 4.5 South America Veterinary Maxingshigan Drug Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Veterinary Maxingshigan Drug Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Veterinary Maxingshigan Drug Sales Quantity by Type (2020-2031)
  • 5.2 Global Veterinary Maxingshigan Drug Consumption Value by Type (2020-2031)
  • 5.3 Global Veterinary Maxingshigan Drug Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Veterinary Maxingshigan Drug Sales Quantity by Application (2020-2031)
  • 6.2 Global Veterinary Maxingshigan Drug Consumption Value by Application (2020-2031)
  • 6.3 Global Veterinary Maxingshigan Drug Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Veterinary Maxingshigan Drug Sales Quantity by Type (2020-2031)
  • 7.2 North America Veterinary Maxingshigan Drug Sales Quantity by Application (2020-2031)
  • 7.3 North America Veterinary Maxingshigan Drug Market Size by Country
    • 7.3.1 North America Veterinary Maxingshigan Drug Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Veterinary Maxingshigan Drug Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Veterinary Maxingshigan Drug Sales Quantity by Type (2020-2031)
  • 8.2 Europe Veterinary Maxingshigan Drug Sales Quantity by Application (2020-2031)
  • 8.3 Europe Veterinary Maxingshigan Drug Market Size by Country
    • 8.3.1 Europe Veterinary Maxingshigan Drug Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Veterinary Maxingshigan Drug Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Veterinary Maxingshigan Drug Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Veterinary Maxingshigan Drug Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Veterinary Maxingshigan Drug Market Size by Region
    • 9.3.1 Asia-Pacific Veterinary Maxingshigan Drug Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Veterinary Maxingshigan Drug Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Veterinary Maxingshigan Drug Sales Quantity by Type (2020-2031)
  • 10.2 South America Veterinary Maxingshigan Drug Sales Quantity by Application (2020-2031)
  • 10.3 South America Veterinary Maxingshigan Drug Market Size by Country
    • 10.3.1 South America Veterinary Maxingshigan Drug Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Veterinary Maxingshigan Drug Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Veterinary Maxingshigan Drug Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Veterinary Maxingshigan Drug Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Veterinary Maxingshigan Drug Market Size by Country
    • 11.3.1 Middle East & Africa Veterinary Maxingshigan Drug Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Veterinary Maxingshigan Drug Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Veterinary Maxingshigan Drug Market Drivers
  • 12.2 Veterinary Maxingshigan Drug Market Restraints
  • 12.3 Veterinary Maxingshigan Drug Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Veterinary Maxingshigan Drug and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Veterinary Maxingshigan Drug
  • 13.3 Veterinary Maxingshigan Drug Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Veterinary Maxingshigan Drug Typical Distributors
  • 14.3 Veterinary Maxingshigan Drug Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Veterinary Maxingshigan Drug. Industry analysis & Market Report on Veterinary Maxingshigan Drug is a syndicated market report, published as Global Veterinary Maxingshigan Drug Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Veterinary Maxingshigan Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report